These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 10701154)

  • 41. Critical role of ROCK2 activity in facilitating mucosal CD4
    Yang W; Zhou G; Yu T; Chen L; Yu L; Guo Y; Cong Y; Liu Z
    J Autoimmun; 2018 May; 89():125-138. PubMed ID: 29269245
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Citrobacter rodentium-induced colitis: A robust model to study mucosal immune responses in the gut.
    Koroleva EP; Halperin S; Gubernatorova EO; Macho-Fernandez E; Spencer CM; Tumanov AV
    J Immunol Methods; 2015 Jun; 421():61-72. PubMed ID: 25702536
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Royal Society of Tropical Medicine and Hygiene meeting at Manson House, London, 14 December 1995. Enteropathogenic Escherichia coli--mucosal infection models.
    Frankel G; Phillips AD; Hicks S; Dougan G
    Trans R Soc Trop Med Hyg; 1996; 90(4):347-52. PubMed ID: 8882174
    [TBL] [Abstract][Full Text] [Related]  

  • 44. IL-4 Protects the Mitochondria Against TNFα and IFNγ Induced Insult During Clearance of Infection with Citrobacter rodentium and Escherichia coli.
    Maiti AK; Sharba S; Navabi N; Forsman H; Fernandez HR; Lindén SK
    Sci Rep; 2015 Oct; 5():15434. PubMed ID: 26481427
    [TBL] [Abstract][Full Text] [Related]  

  • 45. CD14(+) macrophages that accumulate in the colon of African AIDS patients express pro-inflammatory cytokines and are responsive to lipopolysaccharide.
    Cassol E; Rossouw T; Malfeld S; Mahasha P; Slavik T; Seebregts C; Bond R; du Plessis J; Janssen C; Roskams T; Nevens F; Alfano M; Poli G; van der Merwe SW
    BMC Infect Dis; 2015 Oct; 15():430. PubMed ID: 26475133
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cytokine production profile in intestinal mucosa of paediatric inflammatory bowel disease.
    Vitale S; Strisciuglio C; Pisapia L; Miele E; Barba P; Vitale A; Cenni S; Bassi V; Maglio M; Del Pozzo G; Troncone R; Staiano A; Gianfrani C
    PLoS One; 2017; 12(8):e0182313. PubMed ID: 28797042
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Is there a role for defensins in IBD?
    Wehkamp J; Stange EF
    Inflamm Bowel Dis; 2008 Oct; 14 Suppl 2():S85-7. PubMed ID: 18816709
    [No Abstract]   [Full Text] [Related]  

  • 48. A defect in epithelial barrier integrity is not required for a systemic response to bacterial antigens or intestinal injury in T cell receptor-alpha gene-deficient mice.
    Sydora BC; Tavernini MM; Doyle J; Fedorak RN
    Inflamm Bowel Dis; 2006 Aug; 12(8):750-7. PubMed ID: 16917231
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Characterization of chemokines and chemokine receptors in two murine models of inflammatory bowel disease: IL-10-/- mice and Rag-2-/- mice reconstituted with CD4+CD45RBhigh T cells.
    Scheerens H; Hessel E; de Waal-Malefyt R; Leach MW; Rennick D
    Eur J Immunol; 2001 May; 31(5):1465-74. PubMed ID: 11465103
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Citrobacter rodentium infection induces MyD88-dependent formation of ubiquitinated protein aggregates in the intestinal epithelium.
    Kaniuk NA; Lam GY; Ma C; Galindo-Mata E; Jones N; Vallance BA; Brumell JH
    J Innate Immun; 2011; 3(1):83-98. PubMed ID: 20962508
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Activation of intestinal epithelial Stat3 orchestrates tissue defense during gastrointestinal infection.
    Wittkopf N; Pickert G; Billmeier U; Mahapatro M; Wirtz S; Martini E; Leppkes M; Neurath MF; Becker C
    PLoS One; 2015; 10(3):e0118401. PubMed ID: 25799189
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The intestinal barrier, an arbitrator turned provocateur in IBD.
    Mehandru S; Colombel JF
    Nat Rev Gastroenterol Hepatol; 2021 Feb; 18(2):83-84. PubMed ID: 33318680
    [No Abstract]   [Full Text] [Related]  

  • 53. Pharmacokinetics and efficacy of orally administered polymeric chloroquine as macromolecular drug in the treatment of inflammatory bowel disease.
    Kanvinde S; Chhonker YS; Ahmad R; Yu F; Sleightholm R; Tang W; Jaramillo L; Chen Y; Sheinin Y; Li J; Murry DJ; Singh AB; Oupický D
    Acta Biomater; 2018 Dec; 82():158-170. PubMed ID: 30342282
    [TBL] [Abstract][Full Text] [Related]  

  • 54. T cells in mouse models of gut inflammation.
    Simpson SJ; de Jong YP; Comiskey M; Terhorst C
    Chem Immunol; 1998; 71():118-38. PubMed ID: 9761951
    [No Abstract]   [Full Text] [Related]  

  • 55. Unsettling facts of life: bacterial commensalism, epithelial adherence, and inflammatory bowel disease.
    Braun J
    Gastroenterology; 2002 Jan; 122(1):228-30. PubMed ID: 11781298
    [No Abstract]   [Full Text] [Related]  

  • 56. Editorial: The impact of microbiota and cytokines on inflammatory bowel disease.
    Kanauchi O; Mitsuyama K
    Curr Pharm Des; 2009; 15(18):2049-50. PubMed ID: 19519442
    [No Abstract]   [Full Text] [Related]  

  • 57. New perspectives of an old cytokine.
    Raza A; Shata MT
    Inflamm Bowel Dis; 2013 Mar; 19(3):E39-40. PubMed ID: 22434682
    [No Abstract]   [Full Text] [Related]  

  • 58. Genes, bacteria, and T cells: ingredients for inflammatory bowel disease.
    Shanahan F; O'Sullivan GC; Collins JK
    Gastroenterology; 1998 Dec; 115(6):1595-6. PubMed ID: 9834293
    [No Abstract]   [Full Text] [Related]  

  • 59. [Properties and etiological role of Citrobacter 019 in acute intestinal diseases].
    Proskuriakova NB; Proleeva VV
    Zh Mikrobiol Epidemiol Immunobiol; 1982 Feb; (2):45-8. PubMed ID: 7090655
    [No Abstract]   [Full Text] [Related]  

  • 60. Sulphation in the colon.
    Jankowski J
    Clin Sci (Lond); 1993 Apr; 84(4):483. PubMed ID: 8482052
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.